L'Occitane venture Duolab launches personalized, on-demand skin care technology in U.K.

March 31, 2020
Accelerating Materials Innovation More...
Acquisition More...
Average importance

Personalization is a major trend in the skin care space that is being enabled by digital tools that can evaluate the skin in real time. Yet with personalization often comes increased cost and complexity, and Duolab's skin care system is no different. Owned by L'Occitane Group, Duolab uses a skin diagnostic tool in the form of an app that can assess the user's skin. The app will recommend a combination of ingredients from three moisturizing bases and five active concentrates. Users are trusted to load the correct combination of capsules into a specialized device to receive a monodose. At £250/device and between £60 and £112 month in capsules, it is unclear if consumers are ready or willing to accept the price and complexity of such a system.

For the original news article, click here .

Further Reading

An introduction to digital pain management

Analyst Insight | November 08, 2019

Introduction Pain management has been a topic of interest for humans for as long as we have been aware that pain is something can be managed. People have used various meditations and mindfulness techniques, electrical impulses, herbal medicine, alcohol, and targeted pharmaceuticals to manage pain... Not part of subscription

Digital Pain Management

Technology | December 10, 2019

Digital tools for the treatment of pain, both acute and chronic, such as apps, implantables, and consumer electronics. Not part of subscription

Digital Therapeutics

State of the Market Report | March 30, 2020

Digital therapeutics are a key element of the ongoing digital transformation of healthcare. These tools support personalized yet scalable health services, which is critical where high costs and accessibility represent barriers to quality healthcare. This report will outline the landscape of digital... Not part of subscription